{"id":481553,"title":"Notice: Multiple additions to the Prescription Drug List (PDL) [2022-12-22] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:57:19.891000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2022-12-22.html?wbdisable=true","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) December 22, 2022 Our file number: 22-113424-10 The purpose of this Notice of Amendment is to notify about the addition of finerenone, lenacapavir, mavacamten, selumetinib, ubrogepant to the Prescription Drug List…","rawSnapshotUrl":"/api/snapshots/raw/481553","browseUrl":"https://replay.healtharchive.ca/job-6/20260106165719/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2022-12-22.html?wbdisable=true#ha_snapshot=481553","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}